Atrial Fibrillation and Other Clinical Manifestations of Altered TBX5 Dosage in Typical Holt-Oram Syndrome
- PMID: 18818409
- PMCID: PMC2740619
- DOI: 10.1161/CIRCRESAHA.108.181834
Atrial Fibrillation and Other Clinical Manifestations of Altered TBX5 Dosage in Typical Holt-Oram Syndrome
Comment on
-
A gain-of-function TBX5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation.Circ Res. 2008 Jun 6;102(11):1433-42. doi: 10.1161/CIRCRESAHA.107.168294. Epub 2008 May 1. Circ Res. 2008. PMID: 18451335
References
-
- Postma AV, van de Meerakker JBA, Mathijssen IB, Barnett P, Christoffels VM, Ilgun A, Lam J, Wilde AAM, Deprez RHL, Moorman AFM. A Gain-of-function TBX5 mutation is associated with Atypical Holt-Oram syndrome and paroxysmal atrial fibrillation. Circ Res. 2008;102:1433–1442. - PubMed
-
- Vaughan CJ, Basson CT. Molecular determinants of atrial and ventricular septal defects and patent ductus arteriosus. Am J Med Genet. 2001;97:304–308. - PubMed
-
- Hatcher CJ, Kim MS, Mah CS, Goldstein MM, Wong B, Mikawa T, Basson CT. TBX5 transcription factor regulates cell proliferation during cardiogenesis. Dev Biol. 2001;230:177–188. - PubMed
-
- Hatcher CJ, Diman N, Kim MS, Pennisi DA, Song Y, Goldstein MM, Mikawa T, Basson CT. A role for Tbx5 in proepicardial cell migration in cardiogenesis. Physiol Genomics. 2004;18:129–140. - PubMed
-
- Liberatore CM, Searcy-Schrick RD, Yutzey KE. Ventricular expression of tbx5 inhibits normal heart chamber development. Dev Biol. 2000;223:169–180. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
